Obesity and the dyslipidaemia of diabetes
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
This video has been archived as it is more than 2 years old. CPD is no longer available.
Paul Durrington discuses the use of statins to tackle obesity, and in particular dislipidaemia in diabetic patients.
He concludes that a statin is almost invariably evidence-based first line treatment in diabetes and metabolic syndrome regardless of whether triglycerides are raised or HDL cholesterol is low.
This lecture was part of the event 'Obesity: epidemiology, complications and management'. It was held at The Royal Society of Medicine in London.
Date of lecture: 24th April 2015
This video is available for iPad via Safari
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- The CPD process for this video has now expired. Previously booked CPD credits can still be accessed after login.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.